![Wan-Jun Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: - $ op 30-06-2026
Wan-Jun Kim is currently Chief Financial Officer & Director at Imbiologics Corp.
since 2024.
Formerly, Mr. Kim was Chief Financial Officer at KoBioLabs, Inc. Education includes undergraduate and graduate degrees from Korea University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMBIOLOGICS CORP. -.--% | 10-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IMBIOLOGICS CORP. | Financieel Directeur/CFO | 12-11-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| KOBIOLABS, INC | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Korea University
 Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KoBioLabs, Inc.
 KoBioLabs, Inc. BiotechnologyHealth Technology Researches and develops microbiome | Health Technology |
Imbiologics Corp.
 Imbiologics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops antibodies for autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
